Report Categories
View AllRecent Articles
View All
Regeneron Pharmaceuticals REGN Bullish Investment Case Strengthens Post FDA Hearing Gene Therapy Approval Amid Temporary Share Pullback
CRNT Ceragon falls 202 after Q4 2025 earnings deliver a narrow 2 percent EPS miss against analyst estimates
FUFU BitFuFu reports deepening Q4 loss missing estimates by wide margin as mining costs rise
CMS CMS Energy notches narrow Q1 2026 EPS beat shares dip marginally in muted postearnings trading
Market Catalysts That Could Deflate the Stock Market Rally
Boston Beer Company SAM Faces Price Target Cut by Morgan Stanley Amid Cost and Macro Headwinds
Lloyds Potential Halifax Brand Phaseout Stirs Local Sentiment and Strategic Questions
HighYield Savings Rates Remain Attractive Top Accounts Offer Up to 41 APY May 2026
Tui Faces Scrutiny After E ColiLinked Death of Baby at Egyptian Resort
Susquehanna Adjusts Power Integrations Price Target Upward
CPSH Q1 2026 Earnings EPS Misses Estimates Stock Rises Over 28
TrioTech International TRT Q3 2024 Earnings Modest Profit Reported Amidst Challenging Environment
NRT Q2 2025 Earnings Trust Reports EPS of 020 Stock Advances 064
DK Q1 2026 Earnings Narrow Profit Beats Deeply Negative Estimates
Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress
ANET Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Climbs
Hexcel HXL Rises 169 as Aerospace Recovery Momentum Gains Traction
ADMA Biologics Inc ADMA Pulls Back from Resistance Key Support Tested
Costamare Inc CMRE Shares Slide Over 4 Key Support Levels in Focus
XTL Biopharmaceuticals XTLB Slips Modestly Holding Above Key Support
RILYT Notes Slide 147 as Interest Rate Sensitivity Weighs on Bond Prices